A phase I followed by a randomized phase II trial of two cycles carboplatin-olaparib followed by olaparib monotherapy versus capecitabine in BRCA-1 or-2 mutated Her2 negative advanced breast cancer as first line treatment (REVIVAL study)

G. M. H. E. Dackus; P. C. Schouten; J. J. Geenen; S. Marchetti; G. S. Sonke; S. C. Linn; J. H. M. Schellens

doi:10.1158/1538-7445.SABCS15-OT1-03-10

A phase I followed by a randomized phase II trial of two cycles carboplatin-olaparib followed by olaparib monotherapy versus capecitabine in BRCA-1 or-2 mutated Her2 negative advanced breast cancer as first line treatment (REVIVAL study)

G. M. H. E. Dackus, P. C. Schouten, J. J. Geenen, S. Marchetti, G. S. Sonke, S. C. Linn, J. H. M. Schellens

Department of Pathology

Research output: Contribution to journal › Meeting Abstract › Academic

Original language	English
Journal	Cancer Research
Volume	76
DOIs	https://doi.org/10.1158/1538-7445.SABCS15-OT1-03-10
Publication status	Published - 15 Feb 2016

Access to Document

10.1158/1538-7445.SABCS15-OT1-03-10

Cite this

Dackus, G. M. H. E., Schouten, P. C., Geenen, J. J., Marchetti, S., Sonke, G. S., Linn, S. C., & Schellens, J. H. M. (2016). A phase I followed by a randomized phase II trial of two cycles carboplatin-olaparib followed by olaparib monotherapy versus capecitabine in BRCA-1 or-2 mutated Her2 negative advanced breast cancer as first line treatment (REVIVAL study). Cancer Research, 76. https://doi.org/10.1158/1538-7445.SABCS15-OT1-03-10

@article{90e4470ba2aa47b39b135c2115994b54,

title = "A phase I followed by a randomized phase II trial of two cycles carboplatin-olaparib followed by olaparib monotherapy versus capecitabine in BRCA-1 or-2 mutated Her2 negative advanced breast cancer as first line treatment (REVIVAL study)",

author = "Dackus, \{G. M. H. E.\} and Schouten, \{P. C.\} and Geenen, \{J. J.\} and S. Marchetti and Sonke, \{G. S.\} and Linn, \{S. C.\} and Schellens, \{J. H. M.\}",

year = "2016",

month = feb,

day = "15",

doi = "10.1158/1538-7445.SABCS15-OT1-03-10",

language = "English",

volume = "76",

journal = "Cancer Research",

issn = "0008-5472",

publisher = "American Association for Cancer Research Inc.",

}

Dackus, GMHE, Schouten, PC, Geenen, JJ, Marchetti, S, Sonke, GS, Linn, SC & Schellens, JHM 2016, 'A phase I followed by a randomized phase II trial of two cycles carboplatin-olaparib followed by olaparib monotherapy versus capecitabine in BRCA-1 or-2 mutated Her2 negative advanced breast cancer as first line treatment (REVIVAL study)', Cancer Research, vol. 76. https://doi.org/10.1158/1538-7445.SABCS15-OT1-03-10

A phase I followed by a randomized phase II trial of two cycles carboplatin-olaparib followed by olaparib monotherapy versus capecitabine in BRCA-1 or-2 mutated Her2 negative advanced breast cancer as first line treatment (REVIVAL study). / Dackus, G. M. H. E.; Schouten, P. C.; Geenen, J. J. et al.
In: Cancer Research, Vol. 76, 15.02.2016.

Research output: Contribution to journal › Meeting Abstract › Academic

TY - JOUR

T1 - A phase I followed by a randomized phase II trial of two cycles carboplatin-olaparib followed by olaparib monotherapy versus capecitabine in BRCA-1 or-2 mutated Her2 negative advanced breast cancer as first line treatment (REVIVAL study)

AU - Dackus, G. M. H. E.

AU - Schouten, P. C.

AU - Geenen, J. J.

AU - Marchetti, S.

AU - Sonke, G. S.

AU - Linn, S. C.

AU - Schellens, J. H. M.

PY - 2016/2/15

Y1 - 2016/2/15

U2 - 10.1158/1538-7445.SABCS15-OT1-03-10

DO - 10.1158/1538-7445.SABCS15-OT1-03-10

M3 - Meeting Abstract

SN - 0008-5472

VL - 76

JO - Cancer Research

JF - Cancer Research

ER -

Dackus GMHE, Schouten PC, Geenen JJ, Marchetti S, Sonke GS, Linn SC et al. A phase I followed by a randomized phase II trial of two cycles carboplatin-olaparib followed by olaparib monotherapy versus capecitabine in BRCA-1 or-2 mutated Her2 negative advanced breast cancer as first line treatment (REVIVAL study). Cancer Research. 2016 Feb 15;76. doi: 10.1158/1538-7445.SABCS15-OT1-03-10